What’s Next After 20 Years Of NICE?
NICE's Growing Importance Has Brought Increasing Scrutiny
Meindert Boysen, head of NICE’s Centre For Health Technology Evaluation, shares advice for companies aiming to get their medicine to patients. His golden rules: engage in early advice and be more realistic about pricing.
